Related Topics
Role of lung lesions in tuberculosis explored
For years scientists have sought to unravel the mystery of why about 90% of people infected by Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB), remain symptom-free for years, while the remaining 10% become sick and may die.…
TB survival mechanism explained
In a new paper, Eric Rubin, professor of immunology and infectious diseases at Harvard School of Public Health and colleagues describe how tuberculosis (TB) bacteria undergo metabolic adaptation to survive attempts by immune system cells to kill them…
Tuberculosis experts address role of immune response
Tuberculosis (TB) remains a major infectious disease global threat, with 8.7 million new cases and 1.4 million deaths worldwide reported in 2011 alone. In the United States, an estimated 10 million to 15 million people are infected. With…
The hard science of saving lives
[Fall 2013 Centennial issue] Understanding the basic biology of infectious disease has been a constant at HSPH since its inception. “We’re one of the few schools of public health that has integrated laboratory science and more classical public…
Tuberculosis researchers explore links between infectious and metabolic diseases
Examining connections between infectious and metabolic diseases is the focus of an October 2013 tuberculosis (TB) symposium, and an accompanying blog, cosponsored by Harvard School of Public Health (HSPH). The 7th Annual New England Tuberculosis Symposium will bring…
Student lands grant to further tuberculosis control in Indonesia
September 26, 2013 — For Philips Loh, the suffering of tuberculosis patients — and the frightening ease with which the disease spreads — was a wake-up call. After working as an intern at a hospital in his native…
New findings in battle against drug-resistant tuberculosis
Sarah Fortune, Melvin J. and Geraldine L. Glimcher associate professor of immunology and infectious diseases, on why some people infected with some "bad actor" strains of M. tuberculosis are at very high risk of getting drug resistant TB,…
Why Public Health? Jemila Kester
July 2013 -- In our video series “Why Public Health?” we ask Harvard School of Public Health students and alumni to talk about what drew them to the field. Jemila Kester, a doctoral student in the Biological Sciences…
HSPH and Ministry of Health of India formalize collaboration on public health issues
May 24, 2013 -- India faces daunting public health challenges. Maternal and infant mortality rates are high. Malaria and tuberculosis persist stubbornly. Noncommunicable diseases such as diabetes and cancer are prevalent and increasing. And many—especially the poor—lack good…
Infectious disease expert works to ban landmines, fight tuberculosis and AIDS
Since the 1980s, infectious disease specialist Anne Goldfeld has worked to ban landmines, treat victims of tuberculosis and HIV/AIDS in Cambodia and Ethiopia, and conduct research aimed at eradicating those diseases. A professor in the Department of Immunology…